Event Calendar
Prev MonthPrev Month Next MonthNext Month
NYS Forum - Tanium - Return to the Workplace
Webinar Only
Albany, NY
Wednesday, October 28, 2020, 1:00 PM - 2:00 PM EDT
Category: Forum Events

Click here to register

Things to know when returning to work in a hybrid environment - Tanium

Although the world stopped, government had to keep moving. COVID-19 is a global shock unlike anything we have seen before. A two-in-one combination of economic and health crisis, it has far-reaching implications for many businesses, not just in terms of the direct financial impact, but also how they are operationally structured. Organizations were forced to rapidly, and radically, transform the way they work, necessitating a new approach to endpoint security and management.  Government organizations have been forced to transition the majority of their organizations to hybrid workforce arrangements. To accommodate this transformation, organizations have upended their traditional IT infrastructure and adopted decentralized networks, cloud-based services, and widespread usage of employees’ personal devices. Join this session to learn about the key use cases to consider amidst the New Normal.


Gary Buonacorsi, Chief Technology Officer, Tanium

Gary has nearly two decades of experience in the IT industry as a transformational leader for Government agencies and Fortune 500 companies. As Tanium’s SLED Chief Technology Officer, Gary is responsible for thought leadership in the public sector, SLED business strategy, and guiding customer security and operations transformations. Additionally, he defines long-term goals for the State and Local Government vertical, leads industry discussions, and conducts conference keynotes and seminars.  Gary comes to Tanium with a wide range of experience. Most recently he served as the State and Local Government CTO for Dell Technologies. Additionally, Gary’s career includes positions as CTO and CIO at the States of Nevada and Texas, along with Senior Director and Managerial roles at Dell EMC, Oracle and Merck-Medco.